Despite a persistent sense of uncertainty in the AgTech market lately, we’re still seeing startups get acquired– even if information about those acquisitions is opaque. Case in point: Syngenta recently purchased Intrinsyx Bio, a biologicals company, for an undisclosed sum.
Why do companies conceal this information? And in this moment when everyone has their eyes peeled for some indication of where the market is headed, what can we learn from exits?
Sarah sits down this week with Tenacious Ventures’ Matthew Pryor and Shane Thomas, author of Upstream Ag Insights, to do a deep dive into the latest news and discuss what it all means. They tackle:
Useful Links:
The information in this post is not investment advice or a recommendation to invest. It is general information only and does not take into account your investment objectives, financial situation or needs. Before making an investment decision you should seek financial advice from a professional financial adviser. Whilst we believe the information is correct, we provide no warranty of accuracy, reliability or completeness.